Effects of sepsis on neutrophil chemotaxis

Current Opinion in Hematology

Volumn 17, Issue 1, 2010, Pages 18-24

  Reddy, Raju C ^a   Standiford, Theodore J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Immunosuppression; Nitric oxide; Peroxisome proliferator activated receptor g; Systemic inflammatory response syndrome; Toll like receptors

Indexed keywords

CHEMOKINE; CYTOKINE; G PROTEIN COUPLED RECEPTOR; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TOLL LIKE RECEPTOR;

CELL INTERACTION; CYTOSKELETON; ENDOTHELIUM CELL; HIGH TEMPERATURE; HUMAN; IMMUNOMODULATION; INFECTION RISK; INNATE IMMUNITY; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEPSIS; SIGNAL TRANSDUCTION;

ANIMALS; CHEMOTAXIS, LEUKOCYTE; DOWN-REGULATION; HUMANS; NEUTROPHILS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; SEPSIS; SIGNAL TRANSDUCTION;

EID: 73849117987     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32833338f3     Document Type: Review

References (54)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874.
2. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000; 26 (Suppl 1):S64-S74.
3. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420:885-891.
4. Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997; 112:321S-329S.
5. Muller Kobold AC, Tulleken JE, Zijlstra JG, et al. Leukocyte activation in sepsis: correlations with disease state and mortality. Intensive Care Med 2000; 26:883-892.
6. Tavares-Murta BM, Zaparoli M, Ferreira RB, et al. Failure of neutrophil chemotactic function in septic patients. Crit Care Med 2002; 30:1056-1061.
7. Pinheiro da Silva F, Soriano FG. Neutrophils recruitment during sepsis: critical points and crossroads. Front Biosci 2009; 14:4464-4476.
8. Alves-Filho JC, de Freitas A, Spiller F, et al. The role of neutrophils in severe sepsis. Shock 2008; 30 (Suppl 1):3-9.
9. van der Poll T, van Deventer SJ. Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am 1999; 13:413-426.
10. Bone RC, Grodzin CJ, Balk RA. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 1997; 112:235-243.
11. Lyn-Kew K, Standiford TJ. Immunosuppression in sepsis. Curr Pharm Des 2008; 14:1870-1881.
12. Furze RC, Rankin SM. Neutrophil mobilization and clearance in the bone marrow. Immunology 2008; 125:281-288.
13. Furze RC, Rankin SM. The role of the bone marrow in neutrophil clearance under homeostatic conditions in the mouse. FASEB J 2008; 22:3111-3119.
14. Hofman P. Molecular regulation of neutrophil apoptosis and potential targets for therapeutic strategy against the inflammatory process. Curr Drug Targets Inflamm Allergy 2004; 3:1-9.
15. Muller WA. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 2003; 24:327-334.
16. Bokoch GM. Chemoattractant signaling and leukocyte activation. Blood 1995; 86:1649-1660.
17. Katanaev VL. Signal transduction in neutrophil chemotaxis. Biochemistry (Mosc) 2001; 66:351-368.
18. Drost EM, Kassabian G, Meiselman HJ, et al. Increased rigidity and priming of polymorphonuclear leukocytes in sepsis. Am J Respir Crit Care Med 1999; 159:1696-1702.
19. Skoutelis AT, Kaleridis V, Athanassiou GM, et al. Neutrophil deformability in patients with sepsis, septic shock, and adult respiratory distress syndrome. Crit Care Med 2000; 28:2355-2359.
20. Saito H, Lai J, Rogers R, et al. Mechanical properties of rat bone marrow and circulating neutrophils and their responses to inflammatory mediators. Blood 2002; 99:2207-2213.
21. Yoshida K, Kondo R, Wang Q, et al. Neutrophil cytoskeletal rearrangements during capillary sequestration in bacterial pneumonia in rats. Am J Respir Crit Care Med 2006; 174:689-698.
22. Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 2003; 85:85-95.
23. Aomatsu K, Kato T, Fujita H, et al. Toll-like receptor agonists stimulate human neutrophil migration via activation of mitogen-activated protein kinases. Immunology 2008; 123:171-180.
24. Salomao R, Brunialti MK, Gomes NE, et al. Toll-like receptor pathway signaling is differently regulated in neutrophils and peripheral mononuclear cells of patients with sepsis, severe sepsis, and septic shock. Crit Care Med 2009; 37:132-139.
25. Tang BMP,McLean AS, Dawes IW, et al. The use of gene-expression profiling to identify candidate genes in human sepsis. Am J Respir Crit Care Med 2007; 176:676-684.
26. Mashimo H, Obguro N, Nomura S, et al. Neutrophil chemotaxis and local expression of interleukin-10 in the tolerance of endotoxin-induced uveitis. Invest Opthalmol Vis Sci 2008; 49:5450-5457.
27. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392:565-568.
28. Cummings CJ, Martin TR, Frevert CW, et al. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J Immunol 1999; 162:2341-2346.
29. Alves-Filho JC, Freitas A, Souto FO, et al. Regulation of chemokine receptor by toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc Natl Acad Sci U S A 2009; 106:4018-4023.
30. Herrmann JM, Bernardo J, Long HJ, et al. Sequential chemotactic and phagocytic activation of human polymorphonuclear neutrophils. Infect Immun 2007; 75:3989-3998.
31. Penela P, Ribas C, Mayor F Jr. Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. Cell Signal 2003; 15:973-981.
32. Arraes SM, Freitas MS, da Silva SV, et al. Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation. Blood 2006; 108:2906-2913.
33. Chen S, Lin F, Shin ME, et al. RACK1 regulates directional cell migration by acting on G betagamma at the interface with its effectors PLC beta and PI3K gamma. Mol Biol Cell 2008; 19:3909-3922.
34. Choi M, Salanova B, Rolle S, et al. Short-term heat exposure inhibits inflammation by abrogating recruitment of and nuclear factor-kB activation in neutrophils exposed to chemotactic cytokines. Am J Pathol 2008; 172: 367-777.
35. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001; 357:593-615.
36. Benjamim CF, Ferreira SH, Cunha FQ. Role of nitric oxide in the failure of neutrophil migration in sepsis. J Infect Dis 2000; 182:214-223.
37. Moilanen E, Vuorinen P, Kankaanranta H, et al. Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br J Pharmacol 1993; 109:852-858.
38. Lefer DJ, Jones SP, Girod WG, et al. Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol 1999; 276:H1943-H1950.
39. Ialenti A, Ianaro A, Maffia P, et al. Nitric oxide inhibits leucocyte migration in carrageenin-induced rat pleurisy. Inflamm Res 2000; 49:411-417.
40. Mestriner FL, Spiller F, Laure HJ, et al. Acute-phase protein alpha-1-acid glycoprotein mediates neutrophil migration failure in sepsis by a nitric oxidedependent mechanism. Proc Natl Acad Sci U S A 2007; 104:19595-19600.
41. Lefer DJ, Scalia R, Campbell B, et al. Peroxynitrite inhibits leukocyteendothelial cell interactions and protects against ischemia-reperfusion injury in rats. J Clin Invest 1997; 99:684-691.
42. Torres-Duenas D, Celes MR, Freitas A, et al. Peroxynitrite mediates the failure of neutrophil migration in severe polymicrobial sepsis in mice. Br J Pharmacol 2007; 152:341-352.
43. Clements MK, Siemsen DW, Swain SD, et al. Inhibition of actin polymerization by peroxynitrite modulates neutrophil functional responses. J Leukoc Biol 2003; 73:344-355.
44. Vicente AM, Guillen MI, Alcaraz MJ. Modulation of haem oxygenase-1 expression by nitric oxide and leukotrienes in zymosan-activated macrophages. Br J Pharmacol 2001; 133:920-926.
45. Freitas A, Alves-Filho JC, Secco DD, et al. Heme oxygenase/carbon monoxidebiliverdin pathway down regulates neutrophil rolling, adhesion and migration in acute inflammation. Br J Pharmacol 2006; 149:345-354.
46. Zegdi R, Perrin D, Burdin M, et al. Increased endogenous carbon monoxide production in severe sepsis. Intensive Care Med 2002; 28:793-796.
47. Napimoga MH, Vieira SM, Dal-Secco D, et al. Peroxisome proliferatoractivated receptor-gamma ligand, 15-deoxy-delta12,14-prostaglandin J2, reduces neutrophil migration via a nitric oxide pathway. J Immunol 2008; 180:609-617.
48. Reddy RC, Narala VR, Keshamouni VG, et al. Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferatoractivated receptor-g. Blood 2008; 112:4250-4258.
49. Becker J, Delayre-Orthez C, Frossard N, et al. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? Fund Clin Pharmacol 2006; 20:429-447.
50. Gasser O, Hess C, Miot S, et al. Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. Exp Cell Res 2003; 285:243-257.
51. Walenta KL, Link A, Friedrich EB, Bohm M. Circulating microparticles in septic shock. Am J Respir Crit Care Med 2009; 180:100-108.
52. Mortaza S, Martinez MC, Baron-Menguy C, et al. Detrimental hemodynamic and inflammatory effects of microparticles originating from septic rats. Crit Care Med 2009; 37:2045-2050.
53. Nolan S, Dixon R, Norman K, et al. Nitric oxide regulates neutrophil migration through microparticle formation. Am J Pathol 2008; 172:265-273.
54. Dalli J, Norling LV, Renshaw D, et al. Annexin 1 mediates the rapid antiinflammatory effects of neutrophil-derived microparticles. Blood 2008; 112:2512-2519.